Tango Therapeutics TNGX
NASDAQ TNGX
$23.24 -1.21 (-4.95%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tango Therapeutics (TNGX) Cash & Current Investments (2020 - 2026)

Updated

Tango Therapeutics' Cash & Current Investments came in at $1.01 billion for Q2 2026, up 460.9% from $180.79 million a year earlier and up 167.0% from the prior quarter.

Analysis

Tango Therapeutics (TNGX) Cash & Current Investments (2020 - 2026) Analysis & Trends

At the end of FY2025, Tango Therapeutics' Cash & Current Investments was $343.14 million, up 31.7% from FY2024.

  • Cash & Current Investments carries a five-year compound annual growth rate of 12.2% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $260.48 million in FY2024 (-22.7%), $336.89 million in FY2023 (-8.0%), $366.13 million in FY2022 (-24.9%) and $487.53 million in FY2021 (+153.1%).
  • The Q2 2026 figure represents the highest quarterly Cash & Current Investments in data going back to Q2 2020.
  • Year-over-year, Cash & Current Investments has increased for three consecutive quarters, with growth averaging 49.7% over the last eight quarters.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q2 2026 (growth of 460.9%), and the weakest in Q3 2025 (a decline of 47.9%).
  • Business Quant data shows TNGX's Cash & Current Investments at $379.84 million (Q1 2026), $343.14 million (Q4 2025) and $152.81 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Tango Therapeutics 3.91 Bn 2.02 Bn - 1.01 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.01 Bn
Mar 31, 2026 379.84 Mn
Dec 31, 2025 343.14 Mn
Sep 30, 2025 152.81 Mn
Jun 30, 2025 180.79 Mn
Mar 31, 2025 216.72 Mn
Dec 31, 2024 260.48 Mn
Sep 30, 2024 293.28 Mn
Jun 30, 2024 322.11 Mn
Mar 31, 2024 343.60 Mn
Dec 31, 2023 336.89 Mn
Sep 30, 2023 359.88 Mn
Jun 30, 2023 310.65 Mn
Mar 31, 2023 333.64 Mn
Dec 31, 2022 366.13 Mn
Sep 30, 2022 393.29 Mn
Jun 30, 2022 416.36 Mn
Mar 31, 2022 449.89 Mn
Dec 31, 2021 487.53 Mn
Sep 30, 2021 503.81 Mn
API Access

Tango Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=TNGX&period=max&api_key=YOUR_API_KEY